Abstract

The objective of the study : to study changes in MDR tuberculosis incidence and prevalence among patients with HIV infection in the North-Western Federal District and its regions in 2007-2018. Subjects and methods . The data from FSN Form No. 61 on Information on HIV Infected Patients Contingents for 2007-2018, materials of Federal Research Institute for Health Organization and Informatics by the Russian Ministry of Health, information from tables additionally developed by the authors were used. Epidemiological and statistical methods were applied; the differences between the variables were established by the Fisher coefficient based on the Statistica software. Results . The increase in the incidence of TB/HIV co-infection is the highest in regions with the low cumulation of HIV infection: Arkhangelsk, Pskov Regions and the Komi Republic. In 2018, MDR TB among HIV patients with HIV was the most prevalent in Leningrad Region (37.7%), the Komi Republic (32.2%) and Novgorod Region (29.3%), while in the Republic of Karelia, there was not a single case of MDR TB detected among HIV patients, in Pskov Region - 2.4% of cases. The efficacy of tuberculosis chemotherapy by regimens IV-V among the MDR TB/HIV cohort was statistically significantly lower than that of the entire MDR TB cohort: 41.4% versus 61.5% (p < 0.04).

Highlights

  • Цель исследования: изучение динамики заболеваемости и распространенности МЛУ-ТБ среди пациентов с ВИЧ-инфекцией в Северо-Западном федеральном округе (СЗФО) и его регионах за 2007-2018 гг

  • T. Association between HIV/AIDS and multi-drug resistance tuberculosis: A systematic review and meta-analysis // PLoS One

Read more

Summary

Introduction

Цель исследования: изучение динамики заболеваемости и распространенности МЛУ-ТБ среди пациентов с ВИЧ-инфекцией в СЗФО и его регионах за 2007-2018 гг. Темпы прироста показателей заболеваемости и распространенности ТБ/ВИЧ-и за обзорный период увеличились во всех регионах СЗФО, за ис- РФ СЗФО Арх Вол Клг Кар Коми Лен Мурм Нов Псков СПб НАО

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call